Assignee
AUTIFONY THERAPEUTICS LTD
GB·22 granted patents·9 pending applications·76 citations·filing 2012–2025
Top patents by PatentIndex Score
31 records- 0195US10835534B2CompoundsAUTIFONY THERAPEUTICS LTD·Filed 2019·Granted Nov 17, 2020·3 cites·4 claims
- 0295US9422272B2CompoundsAUTIFONY THERAPEUTICS LTD·Filed 2015·Granted Aug 23, 2016·11 cites·2 claims
- 0395US9133175B2CompoundsAUTIFONY THERAPEUTICS LTD·Filed 2012·Granted Sep 15, 2015·18 cites·10 claims
- 0494US11944623B2Modulators of Kv3 channels to treat painAUTIFONY THERAPEUTICS LTD·Filed 2021·Granted Apr 2, 2024·2 cites·20 claims
- 0594US10098881B2CompoundsAUTIFONY THERAPEUTICS LTD·Filed 2017·Granted Oct 16, 2018·8 cites·14 claims
- 0693US9833452B2CompoundsAUTIFONY THERAPEUTICS LTD·Filed 2016·Granted Dec 5, 2017·7 cites·1 claims
- 0788US10555945B2CompoundsAUTIFONY THERAPEUTICS LTD·Filed 2018·Granted Feb 11, 2020·3 cites·17 claims
- 0887US9849131B2Imidazolidinedione derivativesAUTIFONY THERAPEUTICS LTD·Filed 2016·Granted Dec 26, 2017·4 cites·19 claims
- 0986US11197859B2Hydantoin derivatives useful as Kv3 inhibitorsAUTIFONY THERAPEUTICS LTD·Filed 2020·Granted Dec 14, 2021·1 cites·16 claims
- 1086US9216967B2Imidazolidinedione derivativesAUTIFONY THERAPEUTICS LTD·Filed 2014·Granted Dec 22, 2015·5 cites·7 claims
- 1185US10058551B2Imidazolidinedione derivativesAUTIFONY THERAPEUTICS LTD·Filed 2017·Granted Aug 28, 2018·3 cites·12 claims
- 1284US9422252B2Triazoles as Kv3 inhibitorsAUTIFONY THERAPEUTICS LTD·Filed 2013·Granted Aug 23, 2016·5 cites·5 claims
- 1381US11147813B2Modulators of KV3 channels to treat painAUTIFONY THERAPEUTICS LTD·Filed 2016·Granted Oct 19, 2021·2 cites·11 claims
- 1481US2025017925A1Modulators of kv3 channels to treat painAUTIFONY THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 1580US11583527B2Hydantoin derivatives useful as Kv3 inhibitorsAUTIFONY THERAPEUTICS LTD·Filed 2021·Granted Feb 21, 2023·0 cites·18 claims
- 1680US10265316B2Hydantoin derivatives useful as Kv3 inhibitorsAUTIFONY THERAPEUTICS LTD·Filed 2017·Granted Apr 23, 2019·1 cites·3 claims
- 1777US11541052B2CompoundsAUTIFONY THERAPEUTICS LTD·Filed 2020·Granted Jan 3, 2023·0 cites·7 claims
- 1876US9669030B2Hydantoin derivatives as Kv3 inhibitorsAUTIFONY THERAPEUTICS LTD·Filed 2013·Granted Jun 6, 2017·3 cites·20 claims
- 1973US11180461B2Triazoles as Kv3 inhibitorsAUTIFONY THERAPEUTICS LTD·Filed 2020·Granted Nov 23, 2021·0 cites·5 claims
- 2071US12358901B2KV3 modulatorsAUTIFONY THERAPEUTICS LTD·Filed 2021·Granted Jul 15, 2025·0 cites·3 claims
- 2171US2025304564A1Novel kv3 modulatorsAUTIFONY THERAPEUTICS LTD·Filed 2025·Application pending·0 cites
- 2270US2020163964A1Imidazolidinedione derivativesAUTIFONY THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 2370US2019192516A1Hydantoin derivatives useful as kv3 inhibitorsAUTIFONY THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 2468US10611735B2Triazoles as Kv3 inhibitorsAUTIFONY THERAPEUTICS LTD·Filed 2018·Granted Apr 7, 2020·0 cites·5 claims
- 2562US2016251340A1Hydantoin derivatives useful as kv3 inhibitorsAUTIFONY THERAPEUTICS LTD·Filed 2016·Application pending·0 cites
- 2659US2024327406A1Potassium channel modulatorsAUTIFONY THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 2758US2016058737A1Imidazolidinedione derivativesAUTIFONY THERAPEUTICS LTD·Filed 2015·Application pending·0 cites
- 2856US10160730B2Triazoles as KV3 inhibitorsAUTIFONY THERAPEUTICS LTD·Filed 2016·Granted Dec 25, 2018·0 cites·30 claims
- 2943US2020039970A1Hydantoin modulators of kv3 channelsAUTIFONY THERAPEUTICS LTD·Filed 2017·Application pending·0 cites
- 3040US2020377485A1Hydantoin modulators of kv3 channelsAUTIFONY THERAPEUTICS LTD·Filed 2016·Application pending·0 cites
- 3137US10934278B2CompoundsAUTIFONY THERAPEUTICS LTD·Filed 2017·Granted Mar 2, 2021·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when AUTIFONY THERAPEUTICS LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →